[250 Pages Report] The real-time e-healthcare system market is projected to record a CAGR of 6.9% during the forecast period, up from US$ 29 Billion in 2020 to reach a valuation of US$ 47 Billion by 2027.
Attributes | Details |
---|---|
Real-Time E-Healthcare System Market CAGR | 6.9% |
Real-Time E-Healthcare System Market (2027) | US$ 47 Billion |
A real-time e-healthcare system is one of the best ways to keep your health records, and track them anytime, without any geographical constraint and the same is expected to rise the sales of real-time e-healthcare systems.
Patients can always stay in touch with their doctors and communicate with them about any health issue & demand for real-time e-healthcare systems spike as they can self-check also for a quick result without the involvement of a third party.
In addition, with advanced technology and rapid innovation, products are being made easier to use, and hence, the demand for real-time e-healthcare systems is anticipated to witness a positive trend.
Manufacturers in the real-time e-healthcare system are improving their products to reach clinical decision making, for patients with chronic diseases like diabetes, cancer, etc., thereby rising their real-time e-healthcare system market share.
Another major factor driving the demand for real-time e-healthcare systems is the rising percentage of geriatrics in the global population, as elderly people are unable to return to medical facilities.
Other factors favouring the sales of real-time e-healthcare systems include improving healthcare infrastructure, rising demand for an integrated healthcare system, and smartphone ubiquity as well as widespread Internet penetration.
The rising awareness among consumers that new methods can help them stay in touch with their caregivers without relying on a third party is fuelling the demand for real-time e-healthcare systems.
The demand for real-time e-healthcare systems has gone a step further due to the latest trend that allows patients to compare their medical records to pre-determined parameters, reducing the need for a third party.
Sales of real-time e-healthcare systems go up as unrivalled level of user friendliness proves to be the market's most powerful driving force of the demand for real-time e-healthcare systems.
WEBeDoctor, e-MDs Chart, iPatientCare EHR, and AccuMed are examples of software products that interact with patients for purposes ranging from reminding them to take their medication to notify changes in their health parameters.
The above-mentioned software is projected to greatly benefit the sales of real-time e-healthcare systems, in turn, demand for real-time e-healthcare systems.
Real-time e-healthcare systems are quickly filling a void in the healthcare sector, as human doctors are unable to work as closely with their individual patients and the same is anticipated to surge the sales of real-time e-healthcare systems.
Sales of real-time e-healthcare systems are on the surge in the United States as the benefits of deploying real-time e-healthcare systems to improve the quality of care provided to patients are already being felt by community health centres.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Technological advancement, increasing disposable income, increase use of online services, increase use of mobile devices, increased health cost and expenditure all contribute to the increased sales of real-time e-healthcare systems.
Demand for real-time e-healthcare systems is on the rise owing to an increasing need for an integrated healthcare system and the rising use of mobile devices in recent years.
Since real-time e-healthcare system reduces medical errors and easily accessible information, the demand for real-time e-healthcare systems has irrespective of where they live.
Sales of real-time e-healthcare systems get hampered due to a lack of iexperienced professionals, high maintenance and service cost, privacy concerns, the complexity of systems.
Less presence of real-time e-healthcare system in rural areas including developed nations like Europe and are acting as a barrier for the sales of real-time e-healthcare systems.
Depending on geographic regions, the real-time e-healthcare market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.
The Asia Pacific accounts for the largest real-time e-healthcare market share due to the improved healthcare infrastructure and high healthcare costs and rising disposable income.
Demand for cloud computing from developed nations like Europe and North America may also increase the demand for real-time e-healthcare systems by the end of forecast period thereby fuelling the sales of real-time e-healthcare systems.
For companies in the healthcare IT industry, the market is proving to be a fiercely competitive environment. To strengthen their real-time e-healthcare system market share, larger companies are acquiring start-ups and niche market players.
Some of the market players in the real-time e-healthcare market are Fitbit, Garmin, Jawbone, Misfit Wearables, DexCom, Medtronic, Abbott, Cerner Corporation, GE Healthcare, Epic Systems Corporation, Medical Information Technology Inc. (MEDITECH).
Report Attributes | Details |
---|---|
Growth rate | CAGR of 6.9% from 2022 to 2032 |
Base year for estimation | 2021 |
Historical data | 2015 to 2020 |
Forecast period | 2022 to 2032 |
Quantitative units | Revenue in USD million, volume in kilotons, and CAGR from 2022 to 2032 |
Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
Segments covered | Type, application, region |
Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia |
Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
Key companies profiled | Fitbit; Garmin; Jawbone; Misfit Wearables; DexCom; Medtronic; Abbott; Cerner Corporation; GE Healthcare; Epic Systems Corporation; Medical Information Technology Inc. (MEDITECH) |
Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The real-time e-healthcare system market is anticipated to attain a CAGR of 6.9% during the forecast period.
The real-time e-healthcare system market size was valued about US$ 29 Bn in 2020.
Fitbit, Garmin, Jawbone, Misfit Wearables, DexCom, Medtronic, Abbott, Cerner Corporation are a few prominent players in the market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Wireless Body Sensor Network Based e-healthcare Systems 5.3.2. Cellular and Smartphone Based e-Healthcare Systems 5.3.3. System on Chip e-healthcare System 5.3.4. Cloud-based e-healthcare Systems 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 Deep-dive segmentation will be available in the sample on request 6. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032 6.3.1. Institutional Sales 6.3.2. Retail Sales 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032 Deep-dive segmentation will be available in the sample on request 7. Global Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia & Pacific 7.3.6. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Product Type 8.2.3. By Distribution Channel 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product Type 8.3.3. By Distribution Channel 8.4. Key Takeaways 9. Latin America Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product Type 9.2.3. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Distribution Channel 9.4. Key Takeaways 10. Europe Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Product Type 10.2.3. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Distribution Channel 10.4. Key Takeaways 11. East Asia Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Product Type 11.2.3. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Distribution Channel 11.4. Key Takeaways 12. South Asia & Pacific Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Thailand 12.2.1.3. Indonesia 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. New Zealand 12.2.1.8. Rest of South Asia & Pacific 12.2.2. By Product Type 12.2.3. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Distribution Channel 12.4. Key Takeaways 13. MEA Real-Time E-Healthcare System Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Product Type 13.2.3. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Distribution Channel 13.4. Key Takeaways 14. Key Countries Real-Time E-Healthcare System Market Analysis 14.1. U.S. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Product Type 14.1.2.2. By Distribution Channel 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Product Type 14.2.2.2. By Distribution Channel 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Product Type 14.3.2.2. By Distribution Channel 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Product Type 14.4.2.2. By Distribution Channel 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Product Type 14.5.2.2. By Distribution Channel 14.6. U.K. 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Product Type 14.6.2.2. By Distribution Channel 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Product Type 14.7.2.2. By Distribution Channel 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Product Type 14.8.2.2. By Distribution Channel 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Product Type 14.9.2.2. By Distribution Channel 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Product Type 14.10.2.2. By Distribution Channel 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Product Type 14.11.2.2. By Distribution Channel 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Product Type 14.12.2.2. By Distribution Channel 14.13. India 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Product Type 14.13.2.2. By Distribution Channel 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Product Type 14.14.2.2. By Distribution Channel 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Product Type 14.15.2.2. By Distribution Channel 14.16. Malaysia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Product Type 14.16.2.2. By Distribution Channel 14.17. Singapore 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Product Type 14.17.2.2. By Distribution Channel 14.18. Australia 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Product Type 14.18.2.2. By Distribution Channel 14.19. New Zealand 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Product Type 14.19.2.2. By Distribution Channel 14.20. GCC Countries 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Product Type 14.20.2.2. By Distribution Channel 14.21. South Africa 14.21.1. Pricing Analysis 14.21.2. Market Share Analysis, 2021 14.21.2.1. By Product Type 14.21.2.2. By Distribution Channel 14.22. Israel 14.22.1. Pricing Analysis 14.22.2. Market Share Analysis, 2021 14.22.2.1. By Product Type 14.22.2.2. By Distribution Channel 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product Type 15.3.3. By Distribution Channel 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Fitbit, Inc. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Garmin Ltd 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. Jawbone 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. Dexcom, Inc. 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Medtronic 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Abbott Laboratories 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Cerner Corporation 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. GE Healthcare 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Epic Systems Corporation 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Medtronic plc 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 16.1.11. Arcadia Healthcare Solutions 16.1.11.1. Overview 16.1.11.2. Product Portfolio 16.1.11.3. Profitability by Market Segments 16.1.11.4. Sales Footprint 16.1.11.5. Strategy Overview 16.1.11.5.1. Marketing Strategy 16.1.11.5.2. Product Strategy 16.1.11.5.3. Channel Strategy 16.1.12. Omada Health 16.1.12.1. Overview 16.1.12.2. Product Portfolio 16.1.12.3. Profitability by Market Segments 16.1.12.4. Sales Footprint 16.1.12.5. Strategy Overview 16.1.12.5.1. Marketing Strategy 16.1.12.5.2. Product Strategy 16.1.12.5.3. Channel Strategy 16.1.13. Comarch SA 16.1.13.1. Overview 16.1.13.2. Product Portfolio 16.1.13.3. Profitability by Market Segments 16.1.13.4. Sales Footprint 16.1.13.5. Strategy Overview 16.1.13.5.1. Marketing Strategy 16.1.13.5.2. Product Strategy 16.1.13.5.3. Channel Strategy 16.1.14. Renesas Electronics Corporation 16.1.14.1. Overview 16.1.14.2. Product Portfolio 16.1.14.3. Profitability by Market Segments 16.1.14.4. Sales Footprint 16.1.14.5. Strategy Overview 16.1.14.5.1. Marketing Strategy 16.1.14.5.2. Product Strategy 16.1.14.5.3. Channel Strategy 16.1.15. MDs, Inc. 16.1.15.1. Overview 16.1.15.2. Product Portfolio 16.1.15.3. Profitability by Market Segments 16.1.15.4. Sales Footprint 16.1.15.5. Strategy Overview 16.1.15.5.1. Marketing Strategy 16.1.15.5.2. Product Strategy 16.1.15.5.3. Channel Strategy 16.1.16. Archer 16.1.16.1. Overview 16.1.16.2. Product Portfolio 16.1.16.3. Profitability by Market Segments 16.1.16.4. Sales Footprint 16.1.16.5. Strategy Overview 16.1.16.5.1. Marketing Strategy 16.1.16.5.2. Product Strategy 16.1.16.5.3. Channel Strategy 16.1.17. Cloud IT Solutions 16.1.17.1. Overview 16.1.17.2. Product Portfolio 16.1.17.3. Profitability by Market Segments 16.1.17.4. Sales Footprint 16.1.17.5. Strategy Overview 16.1.17.5.1. Marketing Strategy 16.1.17.5.2. Product Strategy 16.1.17.5.3. Channel Strategy 16.1.18. Cisco Systems 16.1.18.1. Overview 16.1.18.2. Product Portfolio 16.1.18.3. Profitability by Market Segments 16.1.18.4. Sales Footprint 16.1.18.5. Strategy Overview 16.1.18.5.1. Marketing Strategy 16.1.18.5.2. Product Strategy 16.1.18.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports